Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin effects on lipoprotein kinetics in type 2 diabetes
NCT01334229Phase 3Completed
- Sponsor
- Université Laval
- Start
- Apr 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Université Laval. Started Apr 2011; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01334229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334229.